nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Lomustine—brain cancer	0.214	0.303	CbGbCtD
Oxymorphone—CYP2D6—Hydroxyurea—brain cancer	0.162	0.23	CbGbCtD
Oxymorphone—CYP3A4—Temozolomide—brain cancer	0.16	0.227	CbGbCtD
Oxymorphone—CYP3A4—Lomustine—brain cancer	0.136	0.193	CbGbCtD
Oxymorphone—CYP3A4—Etoposide—brain cancer	0.0329	0.0466	CbGbCtD
Oxymorphone—OPRM1—telencephalic ventricle—brain cancer	0.00931	0.157	CbGeAlD
Oxymorphone—OPRD1—ganglion—brain cancer	0.00849	0.143	CbGeAlD
Oxymorphone—OPRM1—ganglion—brain cancer	0.00579	0.0974	CbGeAlD
Oxymorphone—Intracranial pressure increased—Carmustine—brain cancer	0.00495	0.0215	CcSEcCtD
Oxymorphone—Altered state of consciousness—Temozolomide—brain cancer	0.00433	0.0188	CcSEcCtD
Oxymorphone—Disorientation—Lomustine—brain cancer	0.00423	0.0183	CcSEcCtD
Oxymorphone—Visual disturbance—Lomustine—brain cancer	0.00399	0.0173	CcSEcCtD
Oxymorphone—Lethargy—Lomustine—brain cancer	0.00386	0.0167	CcSEcCtD
Oxymorphone—OPRD1—telencephalon—brain cancer	0.00328	0.0551	CbGeAlD
Oxymorphone—Lung disorder—Temozolomide—brain cancer	0.00282	0.0122	CcSEcCtD
Oxymorphone—Disorientation—Procarbazine—brain cancer	0.00268	0.0116	CcSEcCtD
Oxymorphone—Memory impairment—Temozolomide—brain cancer	0.00255	0.011	CcSEcCtD
Oxymorphone—Visual impairment—Lomustine—brain cancer	0.00252	0.0109	CcSEcCtD
Oxymorphone—OPRM1—brainstem—brain cancer	0.00252	0.0423	CbGeAlD
Oxymorphone—Lethargy—Procarbazine—brain cancer	0.00245	0.0106	CcSEcCtD
Oxymorphone—Diplopia—Procarbazine—brain cancer	0.0024	0.0104	CcSEcCtD
Oxymorphone—OPRM1—telencephalon—brain cancer	0.00223	0.0376	CbGeAlD
Oxymorphone—Drug interaction—Carmustine—brain cancer	0.00223	0.00966	CcSEcCtD
Oxymorphone—Laryngospasm—Etoposide—brain cancer	0.00214	0.00928	CcSEcCtD
Oxymorphone—Buprenorphine—CYP2C9—brain cancer	0.00212	0.504	CrCbGaD
Oxymorphone—Hydromorphone—CYP2C9—brain cancer	0.00209	0.496	CrCbGaD
Oxymorphone—Disorientation—Hydroxyurea—brain cancer	0.00208	0.009	CcSEcCtD
Oxymorphone—Injection site reaction—Carmustine—brain cancer	0.00206	0.00891	CcSEcCtD
Oxymorphone—OPRD1—head—brain cancer	0.00204	0.0343	CbGeAlD
Oxymorphone—Sweating increased—Procarbazine—brain cancer	0.00202	0.00876	CcSEcCtD
Oxymorphone—Depressed level of consciousness—Carmustine—brain cancer	0.002	0.00865	CcSEcCtD
Oxymorphone—OPRK1—head—brain cancer	0.00196	0.0329	CbGeAlD
Oxymorphone—Depressed level of consciousness—Temozolomide—brain cancer	0.00193	0.00836	CcSEcCtD
Oxymorphone—Apnoea—Etoposide—brain cancer	0.00189	0.00818	CcSEcCtD
Oxymorphone—OPRD1—central nervous system—brain cancer	0.00186	0.0313	CbGeAlD
Oxymorphone—Pneumonia—Procarbazine—brain cancer	0.00186	0.00806	CcSEcCtD
Oxymorphone—Pain—Carboplatin—brain cancer	0.00182	0.00787	CcSEcCtD
Oxymorphone—Mental disability—Carmustine—brain cancer	0.00179	0.00778	CcSEcCtD
Oxymorphone—OPRK1—central nervous system—brain cancer	0.00179	0.03	CbGeAlD
Oxymorphone—Anorexia—Lomustine—brain cancer	0.00177	0.00767	CcSEcCtD
Oxymorphone—CYP2D6—hindbrain—brain cancer	0.00176	0.0296	CbGeAlD
Oxymorphone—OPRK1—cerebellum—brain cancer	0.00174	0.0294	CbGeAlD
Oxymorphone—Mental disability—Temozolomide—brain cancer	0.00173	0.00752	CcSEcCtD
Oxymorphone—Body temperature increased—Carboplatin—brain cancer	0.00168	0.00727	CcSEcCtD
Oxymorphone—Hallucination—Procarbazine—brain cancer	0.00165	0.00716	CcSEcCtD
Oxymorphone—Decreased appetite—Lomustine—brain cancer	0.00161	0.007	CcSEcCtD
Oxymorphone—OPRM1—midbrain—brain cancer	0.0016	0.027	CbGeAlD
Oxymorphone—Amnesia—Carmustine—brain cancer	0.0016	0.00692	CcSEcCtD
Oxymorphone—OPRM1—spinal cord—brain cancer	0.00157	0.0263	CbGeAlD
Oxymorphone—Hot flush—Temozolomide—brain cancer	0.00155	0.00672	CcSEcCtD
Oxymorphone—Amnesia—Temozolomide—brain cancer	0.00154	0.00669	CcSEcCtD
Oxymorphone—Flushing—Procarbazine—brain cancer	0.00154	0.00668	CcSEcCtD
Oxymorphone—Menopausal symptoms—Temozolomide—brain cancer	0.00154	0.00666	CcSEcCtD
Oxymorphone—Diplopia—Carmustine—brain cancer	0.0015	0.00651	CcSEcCtD
Oxymorphone—OPRD1—brain—brain cancer	0.00148	0.0249	CbGeAlD
Oxymorphone—Body temperature increased—Lomustine—brain cancer	0.00147	0.00636	CcSEcCtD
Oxymorphone—Diplopia—Temozolomide—brain cancer	0.00145	0.00629	CcSEcCtD
Oxymorphone—Tension—Procarbazine—brain cancer	0.00142	0.00615	CcSEcCtD
Oxymorphone—OPRK1—brain—brain cancer	0.00142	0.0238	CbGeAlD
Oxymorphone—OPRM1—endocrine gland—brain cancer	0.00141	0.0237	CbGeAlD
Oxymorphone—Nervousness—Procarbazine—brain cancer	0.0014	0.00608	CcSEcCtD
Oxymorphone—OPRM1—head—brain cancer	0.00139	0.0234	CbGeAlD
Oxymorphone—Dehydration—Temozolomide—brain cancer	0.00135	0.00585	CcSEcCtD
Oxymorphone—Syncope—Procarbazine—brain cancer	0.0013	0.00562	CcSEcCtD
Oxymorphone—Hallucination—Hydroxyurea—brain cancer	0.00128	0.00554	CcSEcCtD
Oxymorphone—Loss of consciousness—Procarbazine—brain cancer	0.00127	0.0055	CcSEcCtD
Oxymorphone—OPRM1—central nervous system—brain cancer	0.00127	0.0214	CbGeAlD
Oxymorphone—Abdominal distension—Temozolomide—brain cancer	0.00126	0.00547	CcSEcCtD
Oxymorphone—Convulsion—Procarbazine—brain cancer	0.00125	0.00543	CcSEcCtD
Oxymorphone—Hypertension—Procarbazine—brain cancer	0.00125	0.00541	CcSEcCtD
Oxymorphone—Anxiety—Procarbazine—brain cancer	0.00123	0.00531	CcSEcCtD
Oxymorphone—Sweating increased—Temozolomide—brain cancer	0.00122	0.00529	CcSEcCtD
Oxymorphone—Dry mouth—Procarbazine—brain cancer	0.0012	0.00521	CcSEcCtD
Oxymorphone—Confusional state—Procarbazine—brain cancer	0.00119	0.00515	CcSEcCtD
Oxymorphone—Vomiting—Lomustine—brain cancer	0.00118	0.00512	CcSEcCtD
Oxymorphone—Oedema—Procarbazine—brain cancer	0.00118	0.00511	CcSEcCtD
Oxymorphone—Angiopathy—Hydroxyurea—brain cancer	0.00117	0.00505	CcSEcCtD
Oxymorphone—Pneumonia—Carmustine—brain cancer	0.00116	0.00504	CcSEcCtD
Oxymorphone—Shock—Procarbazine—brain cancer	0.00116	0.00503	CcSEcCtD
Oxymorphone—Tachycardia—Procarbazine—brain cancer	0.00115	0.00499	CcSEcCtD
Oxymorphone—Hyperhidrosis—Procarbazine—brain cancer	0.00114	0.00494	CcSEcCtD
Oxymorphone—Weight decreased—Temozolomide—brain cancer	0.00113	0.00492	CcSEcCtD
Oxymorphone—Pneumonia—Temozolomide—brain cancer	0.00112	0.00487	CcSEcCtD
Oxymorphone—Anorexia—Procarbazine—brain cancer	0.00112	0.00487	CcSEcCtD
Oxymorphone—Nausea—Lomustine—brain cancer	0.0011	0.00478	CcSEcCtD
Oxymorphone—Hypotension—Procarbazine—brain cancer	0.0011	0.00478	CcSEcCtD
Oxymorphone—Insomnia—Procarbazine—brain cancer	0.00107	0.00462	CcSEcCtD
Oxymorphone—Somnolence—Procarbazine—brain cancer	0.00105	0.00454	CcSEcCtD
Oxymorphone—Hallucination—Carmustine—brain cancer	0.00103	0.00448	CcSEcCtD
Oxymorphone—Decreased appetite—Procarbazine—brain cancer	0.00103	0.00444	CcSEcCtD
Oxymorphone—Fatigue—Procarbazine—brain cancer	0.00102	0.00441	CcSEcCtD
Oxymorphone—CYP2D6—brainstem—brain cancer	0.00101	0.017	CbGeAlD
Oxymorphone—Pain—Procarbazine—brain cancer	0.00101	0.00437	CcSEcCtD
Oxymorphone—Constipation—Procarbazine—brain cancer	0.00101	0.00437	CcSEcCtD
Oxymorphone—OPRM1—brain—brain cancer	0.00101	0.017	CbGeAlD
Oxymorphone—Visual impairment—Carmustine—brain cancer	0.001	0.00434	CcSEcCtD
Oxymorphone—Hallucination—Temozolomide—brain cancer	0.000999	0.00433	CcSEcCtD
Oxymorphone—Urinary tract disorder—Temozolomide—brain cancer	0.000991	0.0043	CcSEcCtD
Oxymorphone—Bronchospasm—Etoposide—brain cancer	0.000987	0.00428	CcSEcCtD
Oxymorphone—Urethral disorder—Temozolomide—brain cancer	0.000984	0.00426	CcSEcCtD
Oxymorphone—Sweating increased—Etoposide—brain cancer	0.000977	0.00424	CcSEcCtD
Oxymorphone—Feeling abnormal—Procarbazine—brain cancer	0.000972	0.00421	CcSEcCtD
Oxymorphone—Eye disorder—Carmustine—brain cancer	0.000971	0.00421	CcSEcCtD
Oxymorphone—Convulsion—Hydroxyurea—brain cancer	0.000969	0.0042	CcSEcCtD
Oxymorphone—Visual impairment—Temozolomide—brain cancer	0.000967	0.00419	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Procarbazine—brain cancer	0.000964	0.00418	CcSEcCtD
Oxymorphone—Flushing—Carmustine—brain cancer	0.000964	0.00418	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000946	0.0041	CcSEcCtD
Oxymorphone—Eye disorder—Temozolomide—brain cancer	0.000938	0.00406	CcSEcCtD
Oxymorphone—Urticaria—Procarbazine—brain cancer	0.000937	0.00406	CcSEcCtD
Oxymorphone—Abdominal pain—Procarbazine—brain cancer	0.000932	0.00404	CcSEcCtD
Oxymorphone—Body temperature increased—Procarbazine—brain cancer	0.000932	0.00404	CcSEcCtD
Oxymorphone—Flushing—Temozolomide—brain cancer	0.000932	0.00404	CcSEcCtD
Oxymorphone—Cardiac disorder—Temozolomide—brain cancer	0.000932	0.00404	CcSEcCtD
Oxymorphone—Oedema—Hydroxyurea—brain cancer	0.000913	0.00396	CcSEcCtD
Oxymorphone—Angiopathy—Temozolomide—brain cancer	0.000911	0.00395	CcSEcCtD
Oxymorphone—Mental disorder—Carmustine—brain cancer	0.00091	0.00394	CcSEcCtD
Oxymorphone—Immune system disorder—Temozolomide—brain cancer	0.000907	0.00393	CcSEcCtD
Oxymorphone—Mediastinal disorder—Temozolomide—brain cancer	0.000905	0.00392	CcSEcCtD
Oxymorphone—Malnutrition—Carmustine—brain cancer	0.000904	0.00392	CcSEcCtD
Oxymorphone—Pneumonia—Etoposide—brain cancer	0.0009	0.0039	CcSEcCtD
Oxymorphone—CYP2D6—telencephalon—brain cancer	0.000896	0.0151	CbGeAlD
Oxymorphone—Nervous system disorder—Hydroxyurea—brain cancer	0.000895	0.00388	CcSEcCtD
Oxymorphone—Skin disorder—Hydroxyurea—brain cancer	0.000887	0.00384	CcSEcCtD
Oxymorphone—Mental disorder—Temozolomide—brain cancer	0.000879	0.00381	CcSEcCtD
Oxymorphone—Malnutrition—Temozolomide—brain cancer	0.000874	0.00379	CcSEcCtD
Oxymorphone—Anorexia—Hydroxyurea—brain cancer	0.00087	0.00377	CcSEcCtD
Oxymorphone—Hypersensitivity—Procarbazine—brain cancer	0.000869	0.00377	CcSEcCtD
Oxymorphone—Vision blurred—Carmustine—brain cancer	0.000852	0.00369	CcSEcCtD
Oxymorphone—Asthenia—Procarbazine—brain cancer	0.000846	0.00367	CcSEcCtD
Oxymorphone—Pruritus—Procarbazine—brain cancer	0.000834	0.00362	CcSEcCtD
Oxymorphone—Agitation—Carmustine—brain cancer	0.000831	0.0036	CcSEcCtD
Oxymorphone—Vision blurred—Temozolomide—brain cancer	0.000823	0.00357	CcSEcCtD
Oxymorphone—Dyspnoea—Hydroxyurea—brain cancer	0.000814	0.00353	CcSEcCtD
Oxymorphone—Somnolence—Hydroxyurea—brain cancer	0.000811	0.00352	CcSEcCtD
Oxymorphone—Diarrhoea—Procarbazine—brain cancer	0.000807	0.0035	CcSEcCtD
Oxymorphone—Dyspepsia—Hydroxyurea—brain cancer	0.000804	0.00348	CcSEcCtD
Oxymorphone—Agitation—Temozolomide—brain cancer	0.000803	0.00348	CcSEcCtD
Oxymorphone—Decreased appetite—Hydroxyurea—brain cancer	0.000793	0.00344	CcSEcCtD
Oxymorphone—Urinary tract disorder—Etoposide—brain cancer	0.000793	0.00344	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000788	0.00342	CcSEcCtD
Oxymorphone—Urethral disorder—Etoposide—brain cancer	0.000787	0.00341	CcSEcCtD
Oxymorphone—Fatigue—Hydroxyurea—brain cancer	0.000787	0.00341	CcSEcCtD
Oxymorphone—Vertigo—Temozolomide—brain cancer	0.000785	0.0034	CcSEcCtD
Oxymorphone—Convulsion—Carmustine—brain cancer	0.000783	0.00339	CcSEcCtD
Oxymorphone—Hypertension—Carmustine—brain cancer	0.000781	0.00338	CcSEcCtD
Oxymorphone—Constipation—Hydroxyurea—brain cancer	0.000781	0.00338	CcSEcCtD
Oxymorphone—Pain—Hydroxyurea—brain cancer	0.000781	0.00338	CcSEcCtD
Oxymorphone—Dizziness—Procarbazine—brain cancer	0.00078	0.00338	CcSEcCtD
Oxymorphone—Palpitations—Temozolomide—brain cancer	0.000772	0.00335	CcSEcCtD
Oxymorphone—Chest pain—Carmustine—brain cancer	0.00077	0.00334	CcSEcCtD
Oxymorphone—Anxiety—Carmustine—brain cancer	0.000767	0.00332	CcSEcCtD
Oxymorphone—Convulsion—Temozolomide—brain cancer	0.000757	0.00328	CcSEcCtD
Oxymorphone—Hypertension—Temozolomide—brain cancer	0.000754	0.00327	CcSEcCtD
Oxymorphone—Feeling abnormal—Hydroxyurea—brain cancer	0.000752	0.00326	CcSEcCtD
Oxymorphone—Eye disorder—Etoposide—brain cancer	0.000751	0.00325	CcSEcCtD
Oxymorphone—Vomiting—Procarbazine—brain cancer	0.00075	0.00325	CcSEcCtD
Oxymorphone—Cardiac disorder—Etoposide—brain cancer	0.000745	0.00323	CcSEcCtD
Oxymorphone—Flushing—Etoposide—brain cancer	0.000745	0.00323	CcSEcCtD
Oxymorphone—Confusional state—Carmustine—brain cancer	0.000744	0.00322	CcSEcCtD
Oxymorphone—Dermatitis—Procarbazine—brain cancer	0.000743	0.00322	CcSEcCtD
Oxymorphone—Anxiety—Temozolomide—brain cancer	0.000741	0.00321	CcSEcCtD
Oxymorphone—Headache—Procarbazine—brain cancer	0.000739	0.0032	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000739	0.0032	CcSEcCtD
Oxymorphone—Oedema—Carmustine—brain cancer	0.000738	0.0032	CcSEcCtD
Oxymorphone—Angiopathy—Etoposide—brain cancer	0.000729	0.00316	CcSEcCtD
Oxymorphone—Dry mouth—Temozolomide—brain cancer	0.000728	0.00315	CcSEcCtD
Oxymorphone—Immune system disorder—Etoposide—brain cancer	0.000725	0.00314	CcSEcCtD
Oxymorphone—Mediastinal disorder—Etoposide—brain cancer	0.000724	0.00314	CcSEcCtD
Oxymorphone—Body temperature increased—Hydroxyurea—brain cancer	0.000722	0.00313	CcSEcCtD
Oxymorphone—Tachycardia—Carmustine—brain cancer	0.00072	0.00312	CcSEcCtD
Oxymorphone—Confusional state—Temozolomide—brain cancer	0.000719	0.00312	CcSEcCtD
Oxymorphone—Oedema—Temozolomide—brain cancer	0.000713	0.00309	CcSEcCtD
Oxymorphone—Anorexia—Carmustine—brain cancer	0.000703	0.00305	CcSEcCtD
Oxymorphone—Nausea—Procarbazine—brain cancer	0.000701	0.00304	CcSEcCtD
Oxymorphone—Nervous system disorder—Temozolomide—brain cancer	0.000699	0.00303	CcSEcCtD
Oxymorphone—Skin disorder—Temozolomide—brain cancer	0.000693	0.003	CcSEcCtD
Oxymorphone—Hypotension—Carmustine—brain cancer	0.00069	0.00299	CcSEcCtD
Oxymorphone—Hyperhidrosis—Temozolomide—brain cancer	0.000689	0.00299	CcSEcCtD
Oxymorphone—Anorexia—Temozolomide—brain cancer	0.00068	0.00295	CcSEcCtD
Oxymorphone—Hypersensitivity—Hydroxyurea—brain cancer	0.000673	0.00291	CcSEcCtD
Oxymorphone—Insomnia—Carmustine—brain cancer	0.000667	0.00289	CcSEcCtD
Oxymorphone—Dyspnoea—Carmustine—brain cancer	0.000658	0.00285	CcSEcCtD
Oxymorphone—Somnolence—Carmustine—brain cancer	0.000656	0.00284	CcSEcCtD
Oxymorphone—Asthenia—Hydroxyurea—brain cancer	0.000655	0.00284	CcSEcCtD
Oxymorphone—Insomnia—Temozolomide—brain cancer	0.000645	0.00279	CcSEcCtD
Oxymorphone—Decreased appetite—Carmustine—brain cancer	0.000641	0.00278	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Carmustine—brain cancer	0.000637	0.00276	CcSEcCtD
Oxymorphone—Dyspnoea—Temozolomide—brain cancer	0.000636	0.00276	CcSEcCtD
Oxymorphone—Somnolence—Temozolomide—brain cancer	0.000634	0.00275	CcSEcCtD
Oxymorphone—Pain—Carmustine—brain cancer	0.000631	0.00273	CcSEcCtD
Oxymorphone—Constipation—Carmustine—brain cancer	0.000631	0.00273	CcSEcCtD
Oxymorphone—Vertigo—Etoposide—brain cancer	0.000628	0.00272	CcSEcCtD
Oxymorphone—Dyspepsia—Temozolomide—brain cancer	0.000628	0.00272	CcSEcCtD
Oxymorphone—Diarrhoea—Hydroxyurea—brain cancer	0.000625	0.00271	CcSEcCtD
Oxymorphone—Decreased appetite—Temozolomide—brain cancer	0.00062	0.00269	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000616	0.00267	CcSEcCtD
Oxymorphone—Fatigue—Temozolomide—brain cancer	0.000615	0.00266	CcSEcCtD
Oxymorphone—Loss of consciousness—Etoposide—brain cancer	0.000615	0.00266	CcSEcCtD
Oxymorphone—Pain—Temozolomide—brain cancer	0.00061	0.00264	CcSEcCtD
Oxymorphone—Constipation—Temozolomide—brain cancer	0.00061	0.00264	CcSEcCtD
Oxymorphone—Feeling abnormal—Carmustine—brain cancer	0.000608	0.00264	CcSEcCtD
Oxymorphone—Convulsion—Etoposide—brain cancer	0.000606	0.00263	CcSEcCtD
Oxymorphone—Hypertension—Etoposide—brain cancer	0.000604	0.00262	CcSEcCtD
Oxymorphone—Dizziness—Hydroxyurea—brain cancer	0.000604	0.00262	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Carmustine—brain cancer	0.000603	0.00261	CcSEcCtD
Oxymorphone—Chest pain—Etoposide—brain cancer	0.000595	0.00258	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000591	0.00256	CcSEcCtD
Oxymorphone—Feeling abnormal—Temozolomide—brain cancer	0.000588	0.00255	CcSEcCtD
Oxymorphone—Body temperature increased—Carmustine—brain cancer	0.000583	0.00253	CcSEcCtD
Oxymorphone—Abdominal pain—Carmustine—brain cancer	0.000583	0.00253	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Temozolomide—brain cancer	0.000583	0.00253	CcSEcCtD
Oxymorphone—Vomiting—Hydroxyurea—brain cancer	0.00058	0.00252	CcSEcCtD
Oxymorphone—Confusional state—Etoposide—brain cancer	0.000575	0.00249	CcSEcCtD
Oxymorphone—Dermatitis—Hydroxyurea—brain cancer	0.000575	0.00249	CcSEcCtD
Oxymorphone—CYP3A4—endocrine gland—brain cancer	0.000574	0.00966	CbGeAlD
Oxymorphone—Headache—Hydroxyurea—brain cancer	0.000572	0.00248	CcSEcCtD
Oxymorphone—Urticaria—Temozolomide—brain cancer	0.000566	0.00245	CcSEcCtD
Oxymorphone—CYP2D6—endocrine gland—brain cancer	0.000565	0.0095	CbGeAlD
Oxymorphone—Abdominal pain—Temozolomide—brain cancer	0.000564	0.00244	CcSEcCtD
Oxymorphone—Body temperature increased—Temozolomide—brain cancer	0.000564	0.00244	CcSEcCtD
Oxymorphone—CYP2D6—head—brain cancer	0.000558	0.00938	CbGeAlD
Oxymorphone—Tachycardia—Etoposide—brain cancer	0.000557	0.00241	CcSEcCtD
Oxymorphone—Skin disorder—Etoposide—brain cancer	0.000554	0.0024	CcSEcCtD
Oxymorphone—Hyperhidrosis—Etoposide—brain cancer	0.000552	0.00239	CcSEcCtD
Oxymorphone—Anorexia—Etoposide—brain cancer	0.000544	0.00236	CcSEcCtD
Oxymorphone—Hypersensitivity—Carmustine—brain cancer	0.000544	0.00236	CcSEcCtD
Oxymorphone—Nausea—Hydroxyurea—brain cancer	0.000542	0.00235	CcSEcCtD
Oxymorphone—Hypotension—Etoposide—brain cancer	0.000533	0.00231	CcSEcCtD
Oxymorphone—Asthenia—Carmustine—brain cancer	0.000529	0.00229	CcSEcCtD
Oxymorphone—Hypersensitivity—Temozolomide—brain cancer	0.000525	0.00228	CcSEcCtD
Oxymorphone—CYP3A4—central nervous system—brain cancer	0.000517	0.0087	CbGeAlD
Oxymorphone—Asthenia—Temozolomide—brain cancer	0.000512	0.00222	CcSEcCtD
Oxymorphone—CYP2D6—central nervous system—brain cancer	0.000509	0.00856	CbGeAlD
Oxymorphone—Dyspnoea—Etoposide—brain cancer	0.000509	0.0022	CcSEcCtD
Oxymorphone—Somnolence—Etoposide—brain cancer	0.000507	0.0022	CcSEcCtD
Oxymorphone—Diarrhoea—Carmustine—brain cancer	0.000505	0.00219	CcSEcCtD
Oxymorphone—Pruritus—Temozolomide—brain cancer	0.000505	0.00219	CcSEcCtD
Oxymorphone—CYP2D6—cerebellum—brain cancer	0.000498	0.00837	CbGeAlD
Oxymorphone—Decreased appetite—Etoposide—brain cancer	0.000496	0.00215	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Etoposide—brain cancer	0.000493	0.00213	CcSEcCtD
Oxymorphone—Fatigue—Etoposide—brain cancer	0.000492	0.00213	CcSEcCtD
Oxymorphone—Dizziness—Carmustine—brain cancer	0.000488	0.00211	CcSEcCtD
Oxymorphone—Constipation—Etoposide—brain cancer	0.000488	0.00211	CcSEcCtD
Oxymorphone—Pain—Etoposide—brain cancer	0.000488	0.00211	CcSEcCtD
Oxymorphone—Diarrhoea—Temozolomide—brain cancer	0.000488	0.00211	CcSEcCtD
Oxymorphone—Dizziness—Temozolomide—brain cancer	0.000472	0.00204	CcSEcCtD
Oxymorphone—Feeling abnormal—Etoposide—brain cancer	0.00047	0.00204	CcSEcCtD
Oxymorphone—Vomiting—Carmustine—brain cancer	0.000469	0.00203	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Etoposide—brain cancer	0.000467	0.00202	CcSEcCtD
Oxymorphone—Dermatitis—Carmustine—brain cancer	0.000465	0.00201	CcSEcCtD
Oxymorphone—Headache—Carmustine—brain cancer	0.000462	0.002	CcSEcCtD
Oxymorphone—Vomiting—Temozolomide—brain cancer	0.000453	0.00196	CcSEcCtD
Oxymorphone—Urticaria—Etoposide—brain cancer	0.000453	0.00196	CcSEcCtD
Oxymorphone—Abdominal pain—Etoposide—brain cancer	0.000451	0.00195	CcSEcCtD
Oxymorphone—Body temperature increased—Etoposide—brain cancer	0.000451	0.00195	CcSEcCtD
Oxymorphone—Dermatitis—Temozolomide—brain cancer	0.000449	0.00195	CcSEcCtD
Oxymorphone—Headache—Temozolomide—brain cancer	0.000447	0.00194	CcSEcCtD
Oxymorphone—Nausea—Carmustine—brain cancer	0.000438	0.0019	CcSEcCtD
Oxymorphone—Nausea—Temozolomide—brain cancer	0.000424	0.00184	CcSEcCtD
Oxymorphone—Hypersensitivity—Etoposide—brain cancer	0.00042	0.00182	CcSEcCtD
Oxymorphone—Asthenia—Etoposide—brain cancer	0.000409	0.00177	CcSEcCtD
Oxymorphone—CYP2D6—brain—brain cancer	0.000404	0.0068	CbGeAlD
Oxymorphone—Pruritus—Etoposide—brain cancer	0.000404	0.00175	CcSEcCtD
Oxymorphone—Diarrhoea—Etoposide—brain cancer	0.00039	0.00169	CcSEcCtD
Oxymorphone—Dizziness—Etoposide—brain cancer	0.000377	0.00164	CcSEcCtD
Oxymorphone—Vomiting—Etoposide—brain cancer	0.000363	0.00157	CcSEcCtD
Oxymorphone—Dermatitis—Etoposide—brain cancer	0.000359	0.00156	CcSEcCtD
Oxymorphone—Headache—Etoposide—brain cancer	0.000357	0.00155	CcSEcCtD
Oxymorphone—Nausea—Etoposide—brain cancer	0.000339	0.00147	CcSEcCtD
